Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center

doi:10.1128/JCM.01834-08

. 2009 Jul;47(7):2279-80.

doi: 10.1128/JCM.01834-08. Epub 2009 May 27.

Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center

Tara Babu¹, Violeta Rekasius, Jorge P Parada, Paul Schreckenberger, Malliswari Challapalli

Affiliations

PMID: 19474267
PMCID: PMC2708468
DOI: 10.1128/JCM.01834-08

Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center

Tara Babu et al. J Clin Microbiol. 2009 Jul.

. 2009 Jul;47(7):2279-80.

doi: 10.1128/JCM.01834-08. Epub 2009 May 27.

Authors

Tara Babu¹, Violeta Rekasius, Jorge P Parada, Paul Schreckenberger, Malliswari Challapalli

Affiliation

¹ Loyola University Health Systems, Maywood, IL 60153, USA.

PMID: 19474267
PMCID: PMC2708468
DOI: 10.1128/JCM.01834-08

Abstract

All patients admitted to our tertiary care hospital from 1 December 2007 to 10 June 2008 were screened for methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) nasal colonization, and the isolates were tested for mupirocin susceptibility by using Etest. Mupirocin resistance (MR) was noted to occur in 3.4% of MRSA carriers, and high-level MR was noted to occur in 0.62% of carriers.

PubMed Disclaimer

Cited by

Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States.
Cadilla A, David MZ, Daum RS, Boyle-Vavra S. Cadilla A, et al. J Clin Microbiol. 2011 Jan;49(1):95-100. doi: 10.1128/JCM.00759-10. Epub 2010 Nov 17. J Clin Microbiol. 2011. PMID: 21084520 Free PMC article.
Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype.
Wolk DM, Blyn LB, Hall TA, Sampath R, Ranken R, Ivy C, Melton R, Matthews H, White N, Li F, Harpin V, Ecker DJ, Limbago B, McDougal LK, Wysocki VH, Cai M, Carroll KC. Wolk DM, et al. J Clin Microbiol. 2009 Oct;47(10):3129-37. doi: 10.1128/JCM.00709-09. Epub 2009 Aug 26. J Clin Microbiol. 2009. PMID: 19710268 Free PMC article.
Dissemination of Methicillin-Resistant Staphylococcus aureus Sequence Type 764 Isolates with Mupirocin Resistance in China.
Guo Y, Xu L, Wang B, Rao L, Xu Y, Wang X, Zhao H, Yu J, Zhou Y, Yu F. Guo Y, et al. Microbiol Spectr. 2023 Feb 14;11(1):e0379422. doi: 10.1128/spectrum.03794-22. Epub 2023 Jan 9. Microbiol Spectr. 2023. PMID: 36622214 Free PMC article.
Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.
Deeny SR, Worby CJ, Tosas Auguet O, Cooper BS, Edgeworth J, Cookson B, Robotham JV. Deeny SR, et al. J Antimicrob Chemother. 2015 Dec;70(12):3366-78. doi: 10.1093/jac/dkv249. Epub 2015 Sep 3. J Antimicrob Chemother. 2015. PMID: 26338047 Free PMC article.
LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus.
Nilsson AC, Janson H, Wold H, Fugelli A, Andersson K, Håkangård C, Olsson P, Olsen WM. Nilsson AC, et al. Antimicrob Agents Chemother. 2015 Jan;59(1):145-51. doi: 10.1128/AAC.03513-14. Epub 2014 Oct 20. Antimicrob Agents Chemother. 2015. PMID: 25331699 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Annigeri, R., J. Conly, S. Vas, et al. 2001. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int. 21554-559. - PubMed
1. Capobianco, J. O., C. C. Doran, and R. C. Goldman. 1989. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob. Agents Chemother. 33156-163. - PMC - PubMed
1. Casewell, M. W., and R. L. R. Hill. 1987. Mupirocin (“pesudomonic acid”)—a promising new topical antimicrobial agent. J. Antimicrob. Chemother 191-5. - PubMed
1. Cookson, B. D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 4111-18. - PubMed
1. Fridkin, S. K., H. A. Hill, N. V. Volkova, et al. 2002. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg. Infect. Dis. 8697-701. - PMC - PubMed

MeSH terms

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Annigeri, R., J. Conly, S. Vas, et al. 2001. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int. 21554-559. - PubMed

[2] Annigeri, R., J. Conly, S. Vas, et al. 2001. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int. 21554-559. - PubMed

[3] Capobianco, J. O., C. C. Doran, and R. C. Goldman. 1989. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob. Agents Chemother. 33156-163. - PMC - PubMed

[4] Capobianco, J. O., C. C. Doran, and R. C. Goldman. 1989. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob. Agents Chemother. 33156-163. - PMC - PubMed

[5] Casewell, M. W., and R. L. R. Hill. 1987. Mupirocin (“pesudomonic acid”)—a promising new topical antimicrobial agent. J. Antimicrob. Chemother 191-5. - PubMed

[6] Casewell, M. W., and R. L. R. Hill. 1987. Mupirocin (“pesudomonic acid”)—a promising new topical antimicrobial agent. J. Antimicrob. Chemother 191-5. - PubMed

[7] Cookson, B. D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 4111-18. - PubMed

[8] Cookson, B. D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 4111-18. - PubMed

[9] Fridkin, S. K., H. A. Hill, N. V. Volkova, et al. 2002. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg. Infect. Dis. 8697-701. - PMC - PubMed

[10] Fridkin, S. K., H. A. Hill, N. V. Volkova, et al. 2002. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg. Infect. Dis. 8697-701. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center

Affiliation

Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center

Authors

Affiliation

Abstract

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

References

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical